Member Info for Prion25

PMQ just now PM says 1.2 billion on hydrogen project

Thanks Bobsson and D-Geeman much appreciated

I have these shares sitting H & L account haven 't looked at them for several years .I see they are in dollars .will I still be able to trade them in my H & L accounts

Thanks

My feeling is that they need to accelerate the development of AVA 6103 to commercalisation

Correct BV

Avacta is seeking an investing partner

BV

From refs

Banerji U, Cook N, Anthoney A, Plummer R, Tap WD, Evans JT, Cranmer LD, Plummer C, Loadman P, Lahu G, Jones HS, Kinnersley N, McLaughlin F, Twelves C. 2024. Abstract CT188: A Phase I trial of AVA6000, a Fibroblast Activation Protein (FAP)-released and tumor microenvironment (TME)-targeted doxorubicin peptide drug conjugate in patients with FAP-positive solid tumors. Cancer Research. CT188-CT188 84.7_Supplement

Https://www.pharmaceutical-technology.com/data-insights/ava-6000-avacta-life-sciences-solid-tumor-likelihood-of-approval/

Did somebody post the report recently?

Https://www.pharmaceutical-technology.com/data-insights/ava-6000-avacta-life-sciences-solid-tumor-likelihood-of-approval/

did somebody post the report ?

The endorsement by oncologist Alan Ho of the Sloan Kettering Memorial Hospital NY ticks the box for me Listen to the experts

When i take insulin I expect an immediate response 4 years for a response from AVA6000 is rather long

Avacta Announces Promising Early Efficacy and Safety Data for AVA6000 in the Phase 1a Dose Escalation and Ongoing Enrollment in the Phase 1b Expansion Cohorts

just seen the RNS !

The objective was to extend the cash runaway, not a particularly good price for the divested but hopefully great news for our investment going forward

There is too much good science at stake and high profile celeb publicity demanding PC screening test for men's health as RS asked at PMQ this week There is prospective validation data and real world data computation progressing as we speak that could be accelerated by AI algorithm as EDx medical reported imo

I do not how it will effect Ceres but one thing for sure the Hydrogen economy is constantly evolving in the right direction despite all the negative hype from the sceptics

Berenberg cuts Ceres Power price target to 340 (650) pence - 'buy'

Japan is the pioneer of the hydrogen economy and is key to achieve its net zero .Lets hope the rest of the world follows as the technology evolves and the challenges such as costs are overcome

Https://www.proactiveinvestors.co.uk/companies/news/1066673/ceres-receives-support-from-american-investment-bank-after-bosch-exit-1066673.html#

Https://www.sciencemediacentre.org/expert-reaction-to-edx-medical-press-release-giving-topline-findings-on-a-new-prostate-cancer-screening-test/

No published data long way to go or EDX at least OBD has been clinically validated albeit small and prospective data ongoing patents secured and hopefully greater product sales

I bought with H & L

Just jumped in with a small punt without any research except I notice Sir Chris Evans on the board .I remember him from many years ago when he formed Chiroscience lost small amount then but this sounds fantastic news GLA